Elemene is a naturally occurring compound that can be isolated from the traditional Chinese medicinal herb Curcuma wenyujin, which is used to treat tumors in Chinese folk medicine.
B is inhibited by apoptosis-inducing agents in human cancer cells. [8] [9] [10] Like B-cell lymphoma-2 (Bcl-2) and B-cell lymphoma extra large (Bcl-xL), NF-kappa B itself may serve as a pro-survival agent in various circumstances.
11) The activation of NF-kappa B is known to induce the expression of Bcl-2 and Bcl-xL. [12] [13] [14] [15] [16] Inducible loss of NF-kappa B activity is associated with the down-regulation of anti-apoptotic Bcl-2 family members and the occurence of apoptosis. Furthermore, the promoter regions of both Bcl-2 and Bcl-xL genes contain binding sites for NF-kappa B. [15] [16] [17] On the other hand, Bcl-2 can also stimulate or restore NF-kappa B activity. 18, 19) In the present experiment, we examined whether delemene, an effective antitumor component from Curcuma wenyujin, [1] [2] [3] could affect apoptosis in human lung cancer cells. In order to test whether and how the over-expression of Bcl-2 and Bcl-xL offsets the effect of Curcuma wenyujin on cell growth, we transfected human lung cancer cells with either Bcl-2 or Bcl-xL gene.
MATERIALS AND METHODS

Cell Culture
Human lung carcinoma mucoepidermoid cell line NCI-H292 was purchased from American Type Culture Collection (ATCC, #CRL1848, MD, U.S.A.), and cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS; GIBCO, Invitrogen), 100 U/ml of peni- cillin, and 100 mg/ml of streptomycin (GIBCO, Grand Island, NY, U.S.A.). Cells were incubated in a humidified atmosphere of 5% CO 2 in air at 37°C.
d-Elemene and b-elemene were isolated from the essential oil of Curcuma wenyujin using the method reported in Ref. 1) (assay Ͼ97%, GC). Cells were treated with either d-elemene or b-elemene at concentrations indicated. d-Elemene was prepared as previous description.
2-4)
Determination of Anti-proliferation Activity A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to quantify cell death/viability. Cell death was also determined by DNA fragmentation assay kit (Roche Molecular Biochemicals, Mannheim, Germany), which measures apoptotic cell death by detection of bromodeoxy uridine (BrdU)-labled DNA fragments in the cytoplasm of affected cells. Briefly, DNA fragments in the cytoplasm were labeled with BrdU. After the BrdU-labeled DNA fragments were then isolated from the cells using the solutions provided by the kit, the BrdU-labeled DNA fragments were then detected using an enzyme-linked immunosorbent assay (ELISA) method. The entire assay was performed according to the manufacturer's instruction. Appearance of DNA fragments has been considered as a hallmark of apoptosis.
Quantitation of Cell Apoptosis Apoptotic cells were also evaluated using a Annexin-V fluorescein isothiocyanate (FITC) kit (Alexis, Switzerland) and JC-1 (300 nM, Molecu- DNA Transfection Stable transfection was performed using cationic lipid reagent, LipofectAMINE (Life Technologies, Rockville, MD, U.S.A.). The experiment was carried out according to the manufacturer's instruction. NCI-H292 cells (80-85% confluence) were transfected with 500 ng of plasmid DNA in serum-free conditions. After the cells were incubated for 6 h in serum-free medium containing DNA and LipofectAMINE, an equal volume of growth medium containing 20% serum was then added without removing the transfection mixture. The supernatant was changed with complete medium at 24 h following the start of transfection. At 72 h after transfection, the cells were passaged into the selective medium containing geneticin selective antibiotic, G418. The concentration of G418 for the selection was previously determined by dose-response assay. Positive stablytransfected cells were selected by G418 (0.4 mg/ml) after 2 months.
Western Blot Analysis Cell samples were homogenized with ice-cold PBS and then lysed in a solution containing 8 M urea, 0.1 M Na 2 H 2 PO 4 and 0.01 M Tris-HCl. Supernatants were obtained after centrifugation at 10000ϫg. Proteins were separated on 10% sodium dodecyl sulfate (SDS)-polyacrylamide gels. Proteins were then electrophoretically transferred from the gel onto nitrocellulose membranes and the membranes were blocked for 1 h in phosphate buffered saline (PBS)-Tween buffer containing 5% dry milk powder (fat free) at room temperature. The membranes were then incubated with a primary antibody for 1 h. After washing, the membranes were incubated with a secondary antibody, immunoglobulin G (IgG)-horse-radish peroxidase (HRP) (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.). Finally, they were treated with the reagents in the chemiluminescent detection kit (ECL system, Amersham Pharmacia Biotech, Piscataway, NJ, U.S.A.) according to the manufacturer's instructions. Anti-human actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) was used to detect human actin, which was used as a control for equal loading. Anti-human antibodies: Bcl-2, Bcl-xL, p65, inducible nitric oxide (iNOS) and p38 mitogen-activated protein kinase (p38 MAPK) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). The densities of the protein bands corresponding to the size were determined with a GSP-700 scanner with Quantity One image software (Hercules, CA, U.S.A.).
Nuclear Protein Extraction and NF-kappa B Activity Assay Nuclear protein was isolated according the procedure described. 19) Briefly, NCI-H292 cells were harvested, washed in PBS, and collected by centrifugation. The cell pellet was resuspended in 0.5 ml of 10 mM Tris-HCl (pH 7.5)/5 mM MgCl 2 /0.05% (v/v) Triton X-100 and lysed with 20 strokes in a homogenizer. The homogenate was centrifuged at 10000ϫg for 15 min at 4°C. The pellet was obtained. The nuclei pellet volume was estimated and the pellet was resuspended in an equal volume of 10 mM Tris-HCl (pH 7.4)/5 mM MgCl 2 , followed by the addition of 1 nuclear pellet volume of 1 M NaCl/10 mM Tris-HCl (pH 7.4)/4 mM MgCl 2 . The lysing nucleus was left on ice for 30 min and then centrifuged at 10000ϫg for 15 min at 4°C. The supernatant (nuclear extract) was removed and 80% glycerol was added so that the final glycerol concentration was 20% (v/v). The concentration of the nuclear protein was determined. NF-kappa B activity was measured by an enzyme immunoassay kit from Oxford Biomedical Research (Oxford, MI, U.S.A.), which employed an oligonucleotide containing the DNA binding NF-kappa B consensus sequence. If there is any NFkappa B presented in the sample, it will specifically bind to the oligonucleotide coated on the plate and the DNA-bound NF-kappa B can be selectively recognized by the antibody to NF-kappa B subunit, p50 or p105.
Inhibition of NF-kappa B A recombinant replicationdeficient adenovirus, Ad5IkB, contains an IkB construct in which serines 32 and 36 are mutated to alanines, driven by the cytomegalovirus promoter-enhancer. This mutant IkB cannot be phosphorylated, and therefore irreversibly binds to NF-kappa B, preventing its activation. 20, 21) Ad5IkB (a generous gift from Dr. Z. M. Liu) was used as previously described.
21) The adenovirus, Ad5LacZ, which contains the Escherichia coli b-galactosidase gene, was used as a control. Both viruses were grown in 293 cells and purified as the previous description. 21) For adenovirus infection, sub-confluent cells (ca. 80%) were infected with virus in serum-free medium at multiplicity of infection (MOI) of 10-500 for 12 h. The free virus was then washed off and fresh media containing serum was added to the cells. The cells were cultured for another 12 h before experiments.
Statistical Analysis All results were obtained in at least three independent experiments. Data were expressed as meansϮstandard error. Representative data were analyzed for statistical significance by software SPSS11.5. Differences among groups were analyzed by One-way analysis of variance (ANOVA), multiple comparisons used LSD and SNK's test for homogeneity of variance and Dunnett's T3-test for heterogeneity of variance. pϽ0.05 was considered statistically significant.
RESULTS d d-Elemene
Induced Cell Death in Dose-and Time-Dependent Manners d-Elemene induced NCI-H292 cell death in a dose-dependent manner between the concentrations of 0 and 400 mM ( Fig. 2A) . At the concentration of 400 mM, over 80% of the cells were dead after 24-h treatment. Compared with 12-h treatment with 200 mM of d-elemene, the cell death was gradually increased to about 2.4 folds and 2.9 folds after 24-h and 48-h treatments with d-elemene respectively. Both the dose-and the time-dependent manners were similar to the results obtained when the cells were treated with b-elemene (Fig. 2) .
DNA Fragmentation in NCI-H292 Cells Treated with d d-Elemene
The cell death induced by either d-elemene or b-elemene was mainly caused by apoptosis, as the similar result was obtained by DNA fragmentation assay (Fig. 3) . The occurrence of DNA fragment is a typical Marker for apoptosis. d-Elemene is able to significantly induce DNA fragmentation in a dose-and time-dependent manner. There was 4.4 fold increase in 200 mM d-elemene for 24 h with vector control cells (Fig. 3A) ; and the amount of DNA fragmentation was elevated after treatment for 12 h (3.9 fold that of the vector control), and it peaked at 48 h (5.1 fold that of the vector control) after treatment with 200 mM d-elemene (Fig. 3B) .
Cell Death Induced by d d-Elemene Is in Manner by Apoptosis Apoptosis was measured using flow cytometry to quantify the levels of detectable phosphatidylserine (PS) externalization on the outer membrane of apoptotic cells and the mitochondrial transmembrane potential (Dy m ).
Results showed that apoptosis was triggered after treatment for 12 h (Fig. 4A) . The percentage of early apoptosis represented by (AnV) (Fig. 4B) . Total cell death, which comprised early apoptotic and late apoptotic cells, calculated by the summation of the (AnV) dences of compromised Dy m for 6, 12 or 24 h were 1.94, 3.50 and 6.42 fold with respect to the untreated control, respectively (Fig. 5B) . Furthermore, the rate of early apoptosis in NCI-H292 cells treated with d-elemene was inhibited by GSH or z-DEVD-fmk (Fig. 4C ) for 24 h. d d-Elemene Upregulated the Expression of p38 MAPK and iNOS but Downregulated the Levels of Bcl-2 and BclxL To understand how d-elemene regulates cell death, we measured several cell death-related molecules in NCI-H292 cells treated with d-elemene. By Western blot analysis, we found that the expression of p38 MAPK and iNOS was much higher in the cells treated with d-elemene than those treated with vehicle, whereas the levels of p65, Bcl-2 and Bcl-xL were lower (Fig. 6) . The similar expression patterns of these molecules analyzed were also observed in the cells treated with b-elemene (Fig. 6) .
Over-Expression of Bcl-2 and Bcl-xL Protected Cell Death Induced by d d-Elemene
To investigate how the over-expression of Bcl-2 and Bcl-xL affects the cell death in NCI-H292 induced by d-elemene, we transfected NCI-H292 cells with Bcl-2, Bcl-xL, or pcDNA3.1 plasmids and the cells were named as NCI-H292/Bcl-2, NCI-H292/Bcl-xL and NCI-H292/mock cells respectively. Positive clones were selected by G418 and the over-expression of Bcl-2 or Bcl-xL was confirmed using Western blot (Fig. 7) .
In order to clarify whether the over-expression of Bcl-2 or (Fig. 8) . Following treatment, cell death was measured by MTT assay. The result showed that NCI-H292/Bcl-2 and NCI-H292/Bcl-xL cells had a significantly higher percentage of living cells compared to NCI-H292/mock cells, indicating that the NCI-H292/Bcl-2 and NCI-H292/Bcl-xL transfectants were functional. These cells were then treated with 200 mM of d-elemene (Fig. 8) . While NCI-H292/mock cells displayed marked death in response to d-elemene treatment, NCI-H292/Bcl-2 and NCI-H292/BclxL cells showed approximately 93% and 85% protection from d-elemene-induced death respectively.
Over-Expression of Bcl-2 and Bcl-xL Increased NFkappa B Activity NF-kappa B activity is known to be closely associated with Bcl-2 and Bcl-xL expression. [10] [11] [12] [13] [14] 16, 17) In order to determine how the over-expression of Bcl-2 and Bcl-xL affects the NF-kappa B activity in NCI-H292 cells treated either d-elemene or b-elemene, the cells transfected with either Bcl-2 or Bcl-xL were incubated with 200 mM of d-elemene or b-elemene or vehicles. The nuclear protein was isolated after incubation. The cells transfected with an empty pcDNA3.1 vector and the cells without any transfection were used as controls. NF-kappa B activity was significantly higher in the cells with Bcl-2 or Bcl-xL (Fig. 9) . It appeared that Bcl-2 was more effective in raising NFkappa B activity than Bcl-xL.
Inhibition of NF-kappa B Offsetted the Protective Effect Offered by Bcl-2 and Bcl-xL Since the over-expression of Bcl-2 and Bcl-xL increased the activity of NF-kappa B and protected the cells from apoptosis induced by delemene and b-elemene, it would be interesting to know whether the inhibition of NF-kappa B activity could diminish the protective effect offered by Bcl-2 and Bcl-xL. A super-repressor of NF-kappa B activity (Ad5IkB), which is a mutated non-degradable IkBa resistant to phosphorylation and degradation, was used to inhibit the activity of NF-kappa B. NCI-H292/Bcl-2 cells regained their sensitivity to apoptosis induced by d-elemene after being treated by Ad5IkB (Fig. 10) . However, a significant portion of NCI-H292/Bcl-xL cells was not protected after treated by Ad5IkB (Fig. 10) , suggesting that Bcl-xL could still function, to a certain degree, to protect the cells from death when the activity of NF-kappa B was inhibited. It is noticed that, cell death induced by delemene or b-elemene in both NCI-H292/Bcl-2 and NCI-H292/Bcl-xL cells were prevented when the cells were treated by Ad5IkB (Fig. 10A) , indicating that both Bcl-2 and Bcl-xL lost their anti-apoptotic effects when the activity of NF-kappa B was suppressed. In Fig. 10B , Ad5LacZ, as a control in this experiment, has no effect on the protection of d-elemene-induced cell death by Bcl-2 or Bcl-xL overexpression. 1284 Vol. 34, No. 8 In the present study, we demonstrated that d-elemene was able to induce cell death via an apoptotic pathway and in a similar manner to b-elemene. b-Elemene, as an antitumor drug, is widely applied to clinic in China.
d-Elemene seems to be able to achieve the same efficiency of b-elemene, as both drugs at these concentrations induced a similar number of cell death and also they were able to generate very similar time-course curves. Therefore, by comparing d-elemene with a well-known cell growth inhibitor, 22) such as b-elemene, it will help us to evaluate whether delemene can be considered to be an anti-cancer agent.
The occurrence of DNA fragment is a typical Marker for apoptosis. The Annexin-V FITC binding assay was used to distinguish apoptotic cells from necrotic cells. 23) And mitochondria dysfunction has been recognized as a key step in apoptosis. 24) All of these results show that the apoptosis of NCI-H292 cells with d-elemene is in a time-dependent manner.
In the present study, we found that a number of molecules were altered at protein levels in human lung cancer cells treated by d-elemene. Both p38 MAPK and iNOS were increased by either d-elemene or b-elemene treatment.
NF-kappa B has recently emerged as a major player in a variety of human cancers mainly because of its ability to protect transformed cells from apoptosis. We found that accompanying the decreased NF-kappa B activity by d-elemene was the reduction of two anti-apoptotic Bcl-2 family members, Bcl-2 and Bcl-xL. The finding is not surprising, as both the promoter regions of Bcl-2 and Bcl-xL genes contain binding sites for NF-kappa B and thus their expression is controlled by the activity of NF-kappa B.
14-16) It has been reported that NF-kappa B activity is negatively associated with p38 MAPK. In human melanoma cells, p38 MAPK suppresses NF-kappa B activity, which sensitizes melanoma cells to UV-, ribotoxic and radiomimetic chemicals-induced apoptosis. 25) Although d-elemene also reduces NF-kappa B activity and elevates the level of p38 in human lung cancer cells, the pathway linked these two molecules needs further study.
The decreased NF-kappa B activity, the reduction of Bcl-2 and Bcl-xL levels in the lung cancer cells treated with delemene were in agreement with a significantly increase in the number of cell death and the amount of DNA fragmentation, a classic indicator of apoptosis. In order to further support our findings, we transfected the cells with Bcl-2 or BclxL genes and tested how these transfectants behaved in response to d-elemene stimulation. After transfection with either Bcl-2 or Bcl-xL, the cells showed a significant resistance to the d-elemene treatment and the percentage of cell death was markedly different from those without Bcl-2 or Bcl-xL transfection. And also the activity of NF-kappa B was significantly higher in the cells with Bcl-2 or Bcl-xL genes. The current result may support the notion proposed by the previous reports that Bcl-2 over-expression preserves or restores NF-kappa B and thus inhibits apoptosis. 17, 18) Furthermore, using a super-repressor of NF-kappa B, the sensitivity of the cells with Bcl-2 transfection to d-elemene treatment is superior to that of with Bcl-xL. Therefore, it appears that the protective mechanism of Bcl-2, to some extent, is much more NF-kappa B-dependent than Bcl-xL, in lung cancer cells in response to d-elemene stimulation.
Traditional Chinese herb medicine is usually tranquil, both d-elemene and b-elemene can offer anti-cancer effects prob- ably via a similar mechanism. Nevertheless, further studies need to evaluate d-elemene as an anti-cancer agent and also its side effects. CONCLUSION d-Elemene induced apoptosis in NCI-H292 cells and this apoptotic effect was associated with the high level of p38 and iNOS expression. The apoptotic effect of d-elemene could be significantly offset by over-expression of either Bcl-2 or BclxL. Bcl-2, and to the less extent, Bcl-xL, were able to increase the activity of NF-kappa B, which was a known antiapoptotic molecule in human lung cancer cells. Inhibition of NF-kappa B can restore the ability of d-elemene to induce apoptosis. Therefore, apoptotic effect of d-elemene on lung cancer cells is closely related to the activity of NF-kappa B.
